Invivyd, Inc.股价拉升12.84% 市值涨4551.57万美元

市场透视2025-02-06

北京时间2025年02月06日22时31分，Invivyd, Inc.（IVVD.us）股票出现波动，股价急速上涨12.84%。截至发稿，该股报2.38美元/股，成交量1909.02万股，换手率15.96%，振幅6.16%。最近的财报数据显示，该股实现营业收入9.30百万美元，净利润-60.74百万美元，每股收益-0.51美元，毛利7.94百万美元，市盈率-1.25倍。机构评级方面，在所有3家参与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2509726362?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-06 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2509726362","market":"us","top_or_hot":-1,"title":"Invivyd, Inc.股价拉升12.84% 市值涨4551.57万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年02月06日22时31分，Invivyd, Inc.（IVVD.us）股票出现波动，股价急速上涨12.84%。截至发稿，该股报2.38美元/股，成交量1909.02万股，换手率15.96%，振幅6.16%。最近的财报数据显示，该股实现营业收入9.30百万美元，净利润-60.74百万美元，每股收益-0.51美元，毛利7.94百万美元，市盈率-1.25倍。机构评级方面，在所有3家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223128987c8eaa&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Invivyd, Inc.股价拉升12.84% 市值涨4551.57万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvivyd, Inc.股价拉升12.84% 市值涨4551.57万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-06 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223128987c8eaa&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月06日22时31分，Invivyd, Inc.（IVVD.us）股票出现波动，股价急速上涨12.84%。截至发稿，该股报2.38美元/股，成交量1909.02万股，换手率15.96%，振幅6.16%。最近的财报数据显示，该股实现营业收入9.30百万美元，净利润-60.74百万美元，每股收益-0.51美元，毛利7.94百万美元，市盈率-1.25倍。机构评级方面，在所有3家参与...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223128987c8eaa&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223128987c8eaa&s=b","article_id":"2509726362","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223128987c8eaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2509726362","pubTimestamp":1738852287,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月06日22时31分，Invivyd, Inc.股票出现波动，股价急速上涨12.84%。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3770.97%、335.22%、114.08%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Relmada Therapeutics, Inc.、Invivyd, Inc.，振幅分别为33.33%、14.26%、10.43%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","IVVD":"Invivyd, Inc."},"translate_title":"Invivyd, Inc. 's stock price rose 12.84% and its market value rose by $45.5157 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVVD":1},"content_text":"北京时间2025年02月06日22时31分，Invivyd, Inc.（IVVD.us）股票出现波动，股价急速上涨12.84%。截至发稿，该股报2.38美元/股，成交量1909.02万股，换手率15.96%，振幅6.16%。最近的财报数据显示，该股实现营业收入9.30百万美元，净利润-60.74百万美元，每股收益-0.51美元，毛利7.94百万美元，市盈率-1.25倍。机构评级方面，在所有3家参与评级的机构中，67%的券商给予买入建议，33%的券商给予持有建议，无券商给予卖出建议。Invivyd, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)、Immatics N V C/Wts 01/07/2025 (To Pur Com)涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3770.97%、335.22%、114.08%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Relmada Therapeutics, Inc.、Invivyd, Inc.，振幅分别为33.33%、14.26%、10.43%。Invivyd, Inc.公司简介：Invivyd Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化针对具有大流行潜力的传染病的抗体解决方案。 该公司正在开发抗体，以超越自然产生的免疫力的限制，并从 COVID-19 开始提供针对病毒性疾病的卓越保护。 公司的候选产品是：为治疗和预防冠状病毒病而开发的 ADG20 和 VYD222 是一种经过工程化处理的单克隆抗体候选物，优化了效力和覆盖范围，并提供了在不断发展的病毒环境中更长时间保持其效用的更高可能性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2509726362","isCrawlerRequest":true}